Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “DCPRIME B.V.”

5 pharma patents match "DCPRIME B.V." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "DCPRIME B.V." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “DCPRIME B.V.” · 30,257 patents in full index Clear search

  1. US 11071778

    Combination product for use in tumor vaccination

    DCPRIME B.V. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted

  2. US 11052144

    Methods of tumor vaccination

    DCPRIME B.V. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted

  3. US 11027001

    Therapeutic cancer vaccines derived from a novel dendritic cell line

    DCPRIME B.V. · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted

  4. US 10064923

    Therapeutic cancer vaccines derived from a novel dendritic cell line

    DCPRIME B.V. · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted

  5. US 8470789

    Method for inducing and accelerating cells

    DCPRIME B.V. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.